You are not logged in so some information on this page has been withheld. To see more, please log in or sign up.
2025 › September › 17
J
10 months ago
Johnson & Johnson said its experimental psoriasis drug has shown superior skin clearance compared to Bristol Myers Squibb's Sotyktu in two head-to-head trials.
page 1 of 1